Abstract
Rationale Amid the ongoing coronavirus disease 2019 (COVID-19) pandemic in which many countries have adopted physical distancing measures, tiered restrictions, and episodic “lockdowns,” the impact of potentially increased social mixing during festive holidays on the age distribution of new COVID-19 cases remains unclear.
Objective We aimed to gain insights into possible changes in the age distribution of COVID-19 cases in the UK after temporarily increased intergenerational interactions in late December 2020.
Method We modelled changes in time use and social mixing based on age-stratified contact rates using historical nationally-representative surveys and up-to-date Google mobility data from four weeks before and after the festive period. We explored changes in the effective reproduction number and the age distribution of cases, in four scenarios: (1) “normal”: time use and contact patterns as observed historically, (2) “pre-lockdown”: patterns as seen before the lockdown in November 2020, (3) “lockdown”: patterns restricted as in November 2020, and (4) “festive break”: similar to 3 but with social visits over the holiday period as in 1.
Results Across ages, the estimated Reff decreases during the festive break in scenarios 1-3 and returns to pre-holiday levels in scenarios 2-3, while remaining relatively stable in scenario 4. Relative incidence is likely to decrease in children aged 0-15 but increase in other ages. Changes in age distribution were large during the holidays, and are likely to start before the holidays for individuals aged 16-24 years in scenarios 1-3.
Conclusions Our modelling findings suggest that increased contacts during the festive period may shift the age distribution of COVID-19 cases from children towards adults. Given that COVID-19-related hospitalisations and deaths rise by age, more intergenerational mixing risks an increased burden in the period following the holidays.
Highlights
Home visits are associated with increased intergenerational mixing.
The effective reproduction number is likely to remain stable or even reduce slightly due to a reduction in contacts at work and school.
Relative incidence is likely to become lower in children, but higher in the
older (more vulnerable) age groups around the holiday period, which could lead to increased health care burden.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Public Health England (PHE), which is an executive agency of the Department of Health and Social Care (DHSC). The authors had sole responsibility for the study design, data collection, data analysis, data interpretation, and writing. EvL, FGS, RE, and PJW were supported by the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Modelling and Health Economics, a partnership between PHE, Imperial College London, and LSHTM (grant number NIHR200908). RE was supported by the MRC Centre for Global Infectious Disease analysis (MC_PC 19065) and Health Data Research UK (MR/S003975/1). PJW was supported by the MRC Centre for Global Infectious Disease Analysis (MR/R015600/1); this award is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union (EU). The views expressed are those of the authors and not necessarily those of DHSC, MRC, NHS, NIHR, or PHE.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in the manuscript has been published before.